Affiliation:
1. Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Sector-8 CBD Belapur, Navi Mumbai - 400614, Maharashtra, India.
2. DYPatil Deemed to be University, School of Pharmacy, Nerul, Navi Mumbai.
Abstract
In recent years, the pharmaceutical industry has paid a lot of attention to the idea of "Quality by Design" (QbD) as a means of preserving quality. It acts as a link between the pharmaceutical sector and drug regulatory agencies, enabling us to advance in a process of pharmaceutical product development that is systematic, risk-based, thorough, and efficient. To ensure the quality of predetermined products, it mostly entails creating and implementing production forms and processes. A few QbD components are establishing the quality profile of the intended product, developing the product and production processes, determining the critical quality attributes, process parameters, and resource diversity, and controlling the production processes to produce consistent quality through time. The goal of this article's is to discuss the concept behind quality-based drug design. By describing and demonstrating how it is possible to check the creation and quality of pharmaceuticals.
Reference26 articles.
1. Woodcock J. The concept of pharmaceutical quality [Internet]. Available from: https://www.researchgate.net/publication/279577343
2. Lionberger RA, Lee SL, Lee LM, Raw A, Yu LX. Quality by design: Concepts for ANDAs. Vol. 10, AAPS Journal. 2008. 268–76.
3. Jain S, John S. Quality by design (QBD): A comprehensive understanding of implementation and challenges in pharmaceuticals development [Internet]. Available from: https://www.researchgate.net/publication/280019162
4. ICH guideline Q9 (R1) on quality risk management Step 2b [Internet]. Available from: www.ema.europa.eu/contact
5. Rajora A, Chhabra G. Quality by Design Approach: Regulatory Need, Current, and Future Perspective. 2021; 14: 2021. Available from: http://dx.doi.org/10.22159/ajpcr.2021v14i6.33733.